tbuckley/cabot-search huggingface dataset:
Trial in Progress: A Phase 1b/2 Study of GB5121, a Brain-Penetrant, Potent, Highly Selective, and Irreversible BTK Inhibitor for Relapsed/Refractory Primary/Secondary CNS Lymphoma and Primary Vitreoretinal Lymphoma
Authors: Carole Soussain, Samar Issa, Katharine L Lewis, Christian Grommes, Judith Fox, Renee Ward, Caryn Peterson, Matt Cravets, Anita Mathias, Judith Sosa, Brian J Kirby, Zhaoqing Ding, Isharat Yusuf, Mark J Rose, Marcos W Steinberg, Han W. Tun
Journal: Blood (2022)
A Phase I Study of Safety, Tolerability and Immunological Effects of SVN53-67/M57-KLH in Patients with Multiple Myeloma Receiving Lenalidomide Maintenance Therapy
Authors: Othman Salim Akhtar, Jens Hillengass, Brea Lipe, Sheila A. Figel, Robert A. Fenstermaker, Michael J. Ciesielski, Kelvin P. Lee
Journal: Blood (2022)
IFN-Gamma Is Crucial for the Counterbalance of T Cell-Mediated Injury to the Intestinal Stem Cell Compartment By Regulatory T Cells in Mice and Humans
Authors: Sascha Göttert, Julius Clemens Fischer, Gabriel Eisenkolb, Erik Thiele Orberg, Sebastian Jarosch, Ernst Holler, Dirk Busch, Simon Heidegger, Hendrik Poeck
Journal: Blood (2022)
A Risk-Adapted Study to Assess the Efficacy of Enasidenib and Subsequent Response-Driven Addition of Azacitidine for Newly Diagnosed <i>IDH2</i>-Mutant AML Patients: 3-Year Follow-up
Authors: Eytan Stein, Sheng F Cai, Ying Huang, Andrew Dunbar, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William G. Blum, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark R. Litzow, Tara L. Lin, Prapti A. Patel, Matthew C. Foster, Michael M. Boyiadzis, Robert H. Collins, Jordan Chervin, Abigail B. Shoben, Jo-Anne Vergilio, Nyla A. Heerema, Leonard Rosenberg, Timothy Chen, Ashley O. Yocum, Franchesca Druggan, Sonja Marcus, Mona Stefanos, Molly Martycz, Brian J. Druker, Alice S. Mims, Uma Borate, Amy Burd, John C. Byrd, Ross L. Levine
Journal: Blood (2022)
Prevalence of Cancer &amp; Cancer Subtypes and Association with Benzene, Toluene, Ethylbenzene, and Xylene - a Study from the National Health and Nutrition Survey
Authors: Arsh Chowdhary, Prachi Bapat, Inshiya Dawoodi, Lean Alkhatib, Samyukta Varma, Lorena Antonella Velez Diaz, Olia Poursina, Lisa Centeno, Tehmina Hashim, Hai Pan, Preeti Malik, Urvish Patel, Kartik Kalra, Prasannalaxmi Palabindela, Ashish Patil, Geetika Kukreja
Journal: Blood (2022)
Unique Clinical Features and Mutation Profile in <i>De Novo</i> Myelodysplastic Syndromes with MF-1 and a Proposed Model for Distinguishing MDS with MF-2/3 from TN-PMF Based on Clinical and Genetic Covariates
Authors: Junying Wu, Wenjun Zhang, Peihong Zhang, Tiejun Qin, Zefeng Xu, Qi Sun, Yujiao Jia, Shiqiang Qu, Bing Li, Huijun Wang, Lijuan Pan, Jinqin Liu, Yudi Zhang, Xin Yan, Robert Peter Gale, Zhijian Xiao
Journal: Blood (2022)
Predicting the Need for Upfront Bone Marrow Sampling in Individuals with MGUS: Derivation of a Multivariable Prediction Model Using the Prospective Population-Based Istopmm Cohort
Authors: Elias Eythorsson, Sæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, Elin Ruth Reed, Gudrún Ásta Sigurdardóttir, Brynjar Vidarsson, Páll Torfi Onundarson, Bjarni Agnarsson, Margrét Sigurdardóttir, Ísleifur Ólafsson, Ingunn Þorsteinsdóttir, Signy Vala Sveinsdottir, Fridbjorn Sigurdsson, Ásdis Rósa Thórdardottir, Runolfur Palsson, Olafur Indridason, Thorir Einarsson Long, Asbjorn Jonsson, Gauti Kjartan Gislason, Andri Olafsson, Jon Kristinn Sigurdsson, Hlif Steingrimsdottir, Malin Hultcrantz, Brian G.M. Durie, Stephen Harding, Ola Landgren, Thor Aspelund, Thorvardur Jon Love, Sigurdur Y Kristinsson
Journal: Blood (2022)
GPC-100 Is a Novel CXCR4 Inhibitor That Leads to Improved <i>in Vitro</i> Potency and <i>In Vivo</i> Efficacy in Stem Cell Mobilization When Combined with a Beta-Blocker
Authors: Juan Jose Fung, Valerie Chiou, Jaemin Lee, Yongdae Jang, Junhee Choi, Piotr Zalicki, Thomas Cayton, Ashley Chin, Niña Caculitan, SoHui Kim, Jiyeong Lee, Devki Sukhtankar, Eunhee Kim, Josephine Cardarelli
Journal: Blood (2022)
A Phase 1, Open-Label, Dose-Escalation and Expansion, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MT-0169 in Patients with Relapsed or Refractory Multiple Myeloma or Non-Hodgkin Lymphoma
Authors: Bhagirathbhai Dholaria, Admasu Mamuye, Diana Yurewicz, Kristina Dabovic, Amy Yuet, Rafat Abonour, Kevin R. Kelly, Timothy J. Voorhees, Dickran Kazandjian
Journal: Blood (2022)
Impact of Carotid Geometry on Sickle Cell Diseases-Related Cerebral Vasculopthy Development
Authors: Kim-Anh Nguyen-Peyre, Weiqiang Liu, Lazaros Papamanolis, Christian Kassasseya, Nour Belkeziz, Valentin Amar, Gabriel Nahas, Saskia Eckert, Pierre Vedel, Laurène Lenoir, Katy Drémont, Sabine Cleophax, France Pirenne, Frédéric Segonds, Suzanne Verlhac, Irène Vignon-Clémentel, Pablo Bartolucci
Journal: Blood (2022)
"Buprenorphine, It Works So Differently:" Adults with Sickle Cell Disease Describe Their Experiences Transitioning to Buprenorphine for Treatment of Chronic Pain
Authors: Paul C. Loeser, Macy L. Early, C. Patrick Carroll, Shannon Carroll, Ashley Lauriello, Sophie M. Lanzkron, Elizabeth J. Prince, Lydia H. Pecker
Journal: Blood (2022)
Sutimlimab Provides Sustained Improvements in Patient-Reported Outcomes and Quality of Life in Patients with Cold Agglutinin Disease: Open-Label Extension of the Randomized, Phase 3 Cadenza Study
Authors: Alexander Roeth, Catherine M. Broome, Wilma Barcellini, Bernd Jilma, Quentin A. Hill, David Cella, Tor Henrik Anderson Tvedt, Masaki Yamaguchi, Irina Murakhovskaya, Michelle Lee, Frank Shafer, Marek Wardecki, Jennifer Wang, Ronnie Yoo, Jerome Mshijid, Ilene C. Weitz
Journal: Blood (2022)
Mortality in Adults with Sickle Cell Disease: Results from the Sickle Cell Disease Implementation Consortium (SCDIC) Registry
Authors: Franklin Njoku, Norma Pugh, Marsha Treadwell, Jeffrey A. Glassberg, Abdullah Kutlar, Robert Gibson, Nirmish Shah, Victor R. Gordeuk, Lewis L. Hsu, Jane Hankins, Allison A. King, Julie Kanter
Journal: Blood (2022)
Dual CK1ε/PI3Kδ Inhibitor HZ-H08905, Exhibits As a Potential Therapeutic Strategy for Hematologic Malignancies
Authors: Juying Wei, Wenjuan Yu, Hongyan Tong, Min Yang, Miao Hu, Xingguo Liu, Yizhe Wu, Xinglu Zhou, Jie Jin
Journal: Blood (2022)
Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS
Authors: Livius Penter, Yang Liu, Lin Yang, Len Taing, Aashna Jhaveri, Jackson Southard, Manishkumar Patel, Jacquelyn Wolff, Nicole Cullen, Kathleen Pfaff, Nicoletta Cieri, Giacomo Oliveira, Seunghee Kim-Schulze, Srinika Ranasinghe, Rebecca Leonard, Taylor Robertson, Helen Chen, Magdalena Thurin, Shuqiang Li, Scott J. Rodig, Carrie Cibulskis, Stacey Gabriel, Jerome Ritz, Howard Streicher, Donna S. Neuberg, Stephen Hodi, Sacha Gnjatic, Kenneth J Livak, Jennifer Altreuter, Franziska Michor, Robert J Soiffer, Jacqueline S. Garcia, Catherine J. Wu
Journal: Blood (2022)
Real-World Effectiveness and Safety of Venetoclax in Combination with Obinutuzumab in Treatment-Naive CLL Patients - Data from the Observational Study Verve
Authors: Ingo Schwaner, Holger Hebart, Christoph Losem, Thomas Wolff, Kirsten Famulla, Johannes Huelsenbeck, Burkhard Schmidt, Petra Pichler, Davide Rossi, Thomas Noesslinger
Journal: Blood (2022)
CD180 As a Putative Target for Immunotherapy in Aggressive Mature B Cell Lymphomas
Authors: Klaudyna Fidyt, Marta Krawczyk, Monika Pepek, Katsiaryna Marhelava, Agnieszka Kraft, Malgorzata Bobrowicz, Aleksandra Kusowska, Joanna Barankiewicz, Przemyslaw Juszczynski, Michal Smida, Myron Czuczman, Francisco Hernandez-Ilizaliturri, Malgorzata Firczuk, Magdalena Winiarska
Journal: Blood (2022)
Epigenetic Resistance to Menin-MLL1 Inhibition Is Driven By Loss of the Non-Canonical Polycomb Repressive Complex 1.1 in <i>NUP98</i>-Rearranged AML
Authors: Emily B. Heikamp, Jill A Henrich, Hannah E Rice, Sanisha Mahendra-Rajah, Scott A. Armstrong
Journal: Blood (2022)
Outcomes of Axicabtagene Ciloleucel in Comparison with Chemoimmunotherapy (CIT) in an Elderly Population for Treatment of Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) after Two or More Lines of Prior Therapy
Authors: Matthew A. Lunning, Hai-Lin Wang, Zhen-Huan Hu, Frederick L. Locke, Tanya Siddiqi, Caron A. Jacobson, Sairah Ahmed, David B. Miklos, Yi Lin, Brian T. Hill, Armin Ghobadi, Sattva S. Neelapu, Jason Westin, Harry Miao, Shilpa Shahani, Anik R. Patel, Clare Spooner, Christine Fu, Hairong Xu, Marcelo C Pasquini
Journal: Blood (2022)
First in Human Study of Anti-Viral Veto Cells Enabling Successful Engraftment without Severe Gvhd in Non-Myeloablative T Cell Depleted Haploidentical Hematopoietic Stem Cell Transplantation (HSCT)
Authors: Richard E Champlin, Esther Bachar Lustig, Qaiser Bashir, Betul Oran, Steven M. Kornblau, Chitra Hosing, Amin M Alousi, Uday R Popat, Jessica M McCarty, Peter F Thall, Bouthaina S. Dabaja, Wei-Hsin Liu, Giang Dang, Karla Castro, Alejandro Ramirez, Michael Spiotto, Susan Wu, Penny Fang, Indreshpal Kaur, Katy Rezvani, Elizabeth J Shpall, Yair Reisner
Journal: Blood (2022)
Loss of <i>Nr4a1</i> Causes an Elevated Expression of Co-Inhibitory Receptor:Ligand Axes and Results in a Diminished T Cell-Mediated Lymphoma Cell Killing in Aggressive Lymphoma
Authors: Katrin Pansy, Karoline Fechter, Kerstin Wenzl, Aditya Arra, Joseph P. Novak, Marta Szmyra, Sandra Haingartner, Alan G. Ramsay, Anne J. Novak, Hildegard T. Greinix, Christine Beham-Schmid, Peter Neumeister, Alexander J.A. Deutsch
Journal: Blood (2022)
CTX110 Allogeneic CRISPR-Cas9-Engineered CAR T Cells in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Phase 1 Dose Escalation Carbon Study
Authors: Joseph P. McGuirk, Constantine S. Tam, Nicolaus Kröger, Peter A. Riedell, Hemant S. Murthy, Phoebe Joy Ho, Joseph E. Maakaron, Edmund K. Waller, Farrukh T. Awan, Paul J. Shaughnessy, Armin Ghobadi, Michael R. Bishop, Ana Alfonso-Pierola, Michael Dickinson, Praveen Ramakrishnan Geethakumari, Ainsley Ross, William Stevens, Huansheng Xu, Anna Ma, Sarah Beaussant Cohen, Richard T. Maziarz, Carlos Bachier
Journal: Blood (2022)
Efficacy and Safety of Relmacabtagene Autoleucel in Adults with Relapsed/Refractory Follicular Lymphoma in China
Authors: Yuqin Song, Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Jianqiu Wu, Alex Tian, Tony Huang, Zisong Zhou, Meilin Ma, Su Yang, Yun Qin, Jun Zhu
Journal: Blood (2022)
Validation of the Usefulness of Satl-PI and JCOG-PI As Predictors of Prognosis at the Start of Second-Line Treatment
Authors: Daisuke Nakamura, Tomohisa Tabuchi, Naosuke Arima, Maiko Hayashida, Akihiko Arai, Makoto Yoshimitsu, Kenji Ishitsuka
Journal: Blood (2022)
Long Term Survival in Multiple Myeloma Patients: A Multicenter Italian Experience
Authors: Francesca Fazio, Martina Gherardini, Tommaso Za, Elena Rossi, Francesca Di Landro, Sonia Morè, Maria Valentina Manieri, Francesca Fioritoni, Velia Bongarzoni, Svitlana Gumenyuk, Angela Rago, Maria Grazia Garzia, Stefano Angelini, Chiara Masucci, Luca Franceschini, Alfonso Piciocchi, Piero Galieni, Luca De Rosa, Francesco Pisani, Stefano Pulini, Massimo Offidani, Valerio De Stefano, Maurizio Martelli, Maria Teresa Petrucci
Journal: Blood (2022)
Radiation Prior to Chimeric Antigen Receptor T-Cell Therapy Is an Optimizing Bridging Strategy in Relapse/Refractory Aggressive B-Cell Lymphoma
Authors: Qiuxia Yu, Xiaoying Zhang, Na Wang, Liang Huang, Chunrui Li, Yicheng Zhang, Jianfeng Zhou, Gaoxiang Wang, Yang Cao
Journal: Blood (2022)
Comprehensive Geriatric Assessment Is a Useful Tool for Predicting the Outcome of Elderly Patients with Hematologic Malignancies in Real Life
Authors: Isabel González-gascón-y-Marín, Sara Martínez-Flores, Elena Landete, Elena Baeza-Monedero, María Ángeles Foncillas, Paula Fernández-Montalbán, Carolina Cecilia Muñoz-Novas, Maria Stefania Infante, Karen Marín-Mori, Juan Churruca Sarasqueta, Laura Sánchez-Paz, Victoria Ramos-de-Ascanio, Fátima Brañas, José Ángel Hernández-Rivas
Journal: Blood (2022)
Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients &amp;gt;60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study
Authors: Dietger Niederwieser, Dirk Hasenclever, Wolfgang E. Berdel, Bart J. Biemond, Haifa Kathrin Al-Ali, Yves Chalandon, Michel Van Gelder, Christian Junghanss, Goesta Gahrton, Mathias Haenel, Rüdiger Hehlmann, Thomas Heinicke, Andreas Hochhaus, Simona Iacobelli, Rien van Marwijk Kooy, Nicolaus Kröger, Jeroen J.W.M. Janssen, Madlen Jentzsch, Frank Breywisch, Mohamad Mohty, Stavroula Masouridi-Levrat, Gert Ossenkoppele, Jakob Passweg, Wolfram Pönisch, Johannes Schetelig, Christoph Schliemann, Sebastian Schwind, Matthias Stelljes, Peter JM Valk, Bob Lowenberg, Jan J. Cornelissen
Journal: Blood (2022)
Pilot Study Using Induction Chemo-Immunotherapy Followed By Consolidation with Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplant in Advanced Stage Mature Non-Anaplastic T- or NK-Cell Lymphoma/Leukemia in Children, Adolescent, and Young Adults
Authors: Ana C. Xavier, Lauren Harrison, Rodney R. Miles, Stephan Voss, Megan S. Lim, Mitchell S. Cairo
Journal: Blood (2022)
Uncovering Distinct Metabolic Properties of Relapse and Relapse-Fated Clones in B-Cell Acute Lymphoblastic Leukemia
Authors: Sabrina A Smith, Laura Garcia Prat, Mohsen Hosseini, Liqing Jin, Nathan Mbong, Monica Doedens, Jessica McLeod, Julie A. Reisz, Rebecca Wilkerson, Angelo D'Alessandro, Steven M. Chan, Courtney L Jones, John E. Dick
Journal: Blood (2022)
A Novel Serum Free Light Chain Metric Provides Greater Diagnostic Specificity and Robustness to Variation in Renal Function
Authors: Vahid Azimi, Michael J Slade, Mark A Fiala, Julie M Fortier, Keith E Stockerl-Goldstein, John L Frater, Jonathan R Brestoff, Ronald Jackups, Mark A Zaydman
Journal: Blood (2022)
Roles of the SWI/SNF Chromatin Remodelling Factors in Sustaining Oncogenic Transcription Program in T-Cell Acute Lymphoblastic Leukaemia
Authors: Hyoju Kim, Tze King Tan, Xiao Zi Huang, Jolynn Ong, Rui Yokomori, Allen Eng Juh Yeoh, Takaomi Sanda, Shi Hao Tan
Journal: Blood (2022)
Real-World Outcomes in Relapsed/Refractory DLBCL Patients Who Received Polatuzumab Vedotin PLUS Bendamustine and Rituximab or Tafasitamab Plus Lenalidomide By Line of Therapy
Authors: Mehdi Hamadani, Laura Liao, Lauren Wilson, Amanda Howarth, Carlos Flores, Lei Chen
Journal: Blood (2022)
Single-Cell Profiling Reveals Contribution of IFITM1 Expression to Severe CRS in CAR-T-Treated B-ALL
Authors: Mengyi Du, Chenggong Li, Fen Zhou, Wenjing Luo, Yinqiang Zhang, Lu Tang, Jianghua Wu, Huiwen Jiang, Qiuzhe Wei, Haiming Kou, Cong Lu, Chunrui Li, Heng Mei, Yu Hu
Journal: Blood (2022)
Efficacy of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Multiple Myeloma Patients Presenting with Extramedullary Disease: A European Myeloma Network Study (EMN19)
Authors: Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. van der Velden, Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
Journal: Blood (2022)
Efficacy and Safety of Vodobatinib in Patients (pts) with Chronic Phase Philadelphia Positive Chronic Myeloid Leukemia (Ph+ CML): A Sub Group Analysis By Lines of Tyrosine Kinase Inhibitor (TKI) Therapy
Authors: Jorge E. Cortes, Tapan Saikia, Dong-Wook Kim, Yesid Alvarado, Franck E. Nicolini, Krishnakumar Rathnam, Navin Khattry, Sachin Punatar, Jane F. Apperley, Aude Charbonnier, Michael Deininger, Hugues de Lavallade, Nikki Granacher, Carlo Gambacorti-Passerini, Alessandro Lucchesi, Michael Mauro, Peter Vandenberghe, Gregor Verhoef, Andrew R. Whiteley, Arijit Nag, Shashikant Apte, Siu-Long Yao, Sandeep Inamdar, Ruchika Irene Dillu, Jayasree Sreenivasan, Geetanjali Chimote
Journal: Blood (2022)
Characterization of Transcriptional Alterations Leading to Aberrant Myeloid Differentiation in Myelodysplastic Syndromes
Authors: Aintzane Diaz-Mazkiaran, Jesús De la Fuente, Guillermo Serrano, Paula Garcia-Olloqui, Nerea Berastegui, Marina Ainciburu, Ana Alfonso Pierola, Amaia Vilas-Zornoza, Patxi San Martin-Uriz, Jose Maria Lamo De Espinosa, Mikel San Julián, Pamela Acha, Francesc Solé, Tamara Jimenez, Félix López Cadenas, Maria Diez-Campelo, Antonieta Molero, Maria Julia Montoro, David Valcarcel, Teresa Ezponda, Mikel Hernáez, Felipe Prosper
Journal: Blood (2022)
T-Cell Dysfunction in CLL Can be Alleviated By Blocking Sialic Acid-Binding Ig-like Lectin 10 (Siglec-10) Ligation
Authors: Jaco A.C. Van Bruggen, Fleur Peters, Joanne M. Rietveld, Gaspard Cretenet, Joseph Melenhorst, Eric Eldering, Arnon P. Kater
Journal: Blood (2022)
The Effect of Hematopoietic Stem Cell Transplantation on Cerebral Perfusion and Oxygen Metabolism in Patients with Sickle Cell Disease
Authors: Liza Afzali-Hashemi, Koen P.A. Baas, Elisabeth Dovern, Anouk Schrantee, Aart J. Nederveen, Erfan Nur, Bart J. Biemond
Journal: Blood (2022)
Co-Occurrence of <i>TP53/PTEN</i> and <i>CCR4</i> genetic Alteration Deregulates TH-Cell Differentiation and Drives TH2-like Lymphomagenesis and T-Cell Signaling
Authors: Dylan T. Jochum, Waseem G. Lone, Alyssa C. Bouska, Xuxiang Liu, Jiayu Yu, Catalina Amador, Sunandini Sharma, Tyler A. Herek, Wing C. Chan, Javeed Iqbal
Journal: Blood (2022)
Reticulocytosis from Stress Erythropoiesis Is a Major Source of Erythrocyte Mitochondrial Retention, Oxygen Consumption and Reactive Oxygen Species in a SCD Mouse Model
Authors: Anne Gallivan, Amarachi Kanu, Mikail Alejandro, Nebeyat Zekaryas, Hart Horneman, Jagadeesh Ramasamy, Lenny Hong, Donald Lavelle, Alan Diamond, Robert E. Molokie, Elliott P. Vichinsky, Angela Rivers
Journal: Blood (2022)
CCRL2 Promotes Cytokine-Regulated Growth of Erythroleukemia Cells
Authors: Theodoros Karantanos, Christopher Esteb, Patric Teodorescu, Brandy Perkins, Ilias Christodoulou, Stamatia Vorri, Trivikram Rajkhowa, William Brian Dalton, Gabriel Ghiaur, Richard J. Jones
Journal: Blood (2022)
Bispecific CD33/CD123 Targeted Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
Authors: Justin C. Boucher, Bishwas Shrestha, Paresh Vishwasrao, Mark B. Leick, Nhan Tu, Tayyebb Ghafoor, Kayla M. Reid, Kristen Spitler, Bin Yu, Marcela V. Maus, Marco L. Davila
Journal: Blood (2022)
How Relevant Are the Control Cohorts of Clinical Trials in Patients with Newly Diagnosed DLBCL in a Daily Practice?
Authors: Prokop Vodicka, Katerina Benesova, Andrea Janikova, David Belada, Heidi Mocikova, Jan Pirnos, Vit Prochazka, Juraj Duras, Katerina Kopeckova, Katerina Steinerova, Petra Blahovcova, Vit Campr, Pavel Klener, Alice Sykorova, Marek Trneny
Journal: Blood (2022)
Real Life Feasibility of a Combined Clinical and Biological Fitness Assessment in Patients with Acute Myeloid Leukemia
Authors: Raffaele Palmieri, Simona Iacobelli, Giovangiacinto Paterno, Moretti Federico, Elisa Buzzatti, Meddi Elisa, Savi Arianna, Gentiana Trotta, Flavia Mallegni, Maria Ilaria Del Principe, Luca Maurillo, Maria Teresa Voso, Adriano Venditti, Francesco Buccisano
Journal: Blood (2022)
Efficacy and Safety of Daratumumab Monotherapy in Newly Diagnosed Patients with Stage 3B Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network
Authors: Efstathios Kastritis, Monique C. Minnema, Meletios-Athanasios Dimopoulos, Giampaolo Merlini, Foteini Theodorakakou, Despina Fotiou, Antoine Huart, Karim Belhadj, Sreeja Varghese, Kyriaki Manousou, Pieter Sonneveld, Giovanni Palladini
Journal: Blood (2022)
Genetic Alterations of Crebbp Are Associated with Radiosensitivity in Follicular Lymphoma
Authors: Neil Ari Wijetunga, Emily S. Lebow, Jisun Lee, Beatrice Fregonese, Kathryn R. Tringale, Harper Hubbeling, Reith Sarkar, Jennifer Ma, Venkatraman Seshan, Erel Joffe, Ahmet Dogan, Alexander Chan, Guido Wendel, Carla Hajj, Brandon S. Imber, Joachim Yahalom
Journal: Blood (2022)
Impact on Silent Infarct Incidence of Early Screening of the Extracranial Portion of the Internal Carotid in a Longitudinal Cohort-Study of Children with Sickle Cell Anemia
Authors: Françoise Bernaudin, Cécile Arnaud, Annie Kamdem, Isabelle Hau, Fouad Madhi, Ralph Epaud, Camille Jung, Suzanne Verlhac
Journal: Blood (2022)
Non-Coding RNAs Regulate Novel Signaling Pathways in AL Amyloidosis That Are Targetable By BCL2, PI3K and MEK Inhibitors
Authors: Tal Zvida, Eli Muchtar, Mali Salmon-Divon, Angela Dispenzieri, Hila Fishov, Claudio Schneider, Benjamin Bender, Adrian Duek, Merav Leiba, Ofer Shpilberg, Oshrat Hershkovitz-Rokah
Journal: Blood (2022)
CO43923: A Platform Study Evaluating the Safety and Efficacy of Multiple Treatment Combinations in Patients with Multiple Myeloma
Authors: Semira Sheikh, Upen Patil, Kristin Wehrman, Elissavet Sideri, Shannon M. Ruppert, Yanke Yu, Mark Yan, Jasdeep Bhatti, Lydia Pogeza, Yann Nouet
Journal: Blood (2022)
A Phase 2 Evaluation of Daratumumab-Based Induction Therapy in Multiple Myeloma Patients with Severe Renal Insufficiency
Authors: R Donald Harvey, Joseph K Franz, Nisha S. Joseph, Jonathan L. Kaufman, Elise Hitron, Hannah Collins, Catherine Braga, Ludimila Cavalcante, Kathryn T. Maples, Craig C Hofmeister, Madhav Dhodapkar, Sagar Lonial, Ajay K. Nooka
Journal: Blood (2022)
Transcriptional and Epigenetic Dysregulation Drives Erythroid and Megakaryocyte Differentiation Bias in the Spleens of Patients with Advanced Myelofibrosis
Authors: Rebecca Austin, Madeline Kowalski, Xiaoli Wang, Bettina Nadorp, Audrey Lasry, Zhengxi Sun, Julia Rojo-Tomillo, Andrew Davis, Dimitrios Papaioannou, Rahul Satija, Ioannis Aifantis, Ronald Hoffman
Journal: Blood (2022)
Analysis of Bendamustine Lymphodepletion, CD19 CART Expansion, Safety and Efficacy in Patients with Rel/Ref Non-Hodgkin Lymphoma
Authors: Sushma Bharadwaj, Mark P Hamilton, Bita Sahaf, John Tamaresis, Sunita Patil, Paul J Hanson, Theresa Latchford, Sally Arai, Laura J. Johnston, Robert Lowsky, Robert S. Negrin, Andrew R. Rezvani, Judith A Shizuru, Everett H Meyer, Parveen Shiraz, Surbhi Sidana, Melody Smith, Wen-Kai Weng, Lori Muffly, Crystal L. Mackall, Matthew J Frank, David B. Miklos, Saurabh Dahiya
Journal: Blood (2022)
Arginine Deprivation in Microenvironment Makes Multiple Myeloma Resistant to Proteasome Inhibitors Via Increased Lactate Release and Metabolic Rewiring
Authors: Cesarina Giallongo, Grazia Scandura, Alessandro Barbato, Enrico La Spina, Lucia Longhitano, Tatiana Zuppelli, Ilaria Dulcamare, Nunziatina Laura Parrinello, Sebastiano Giallongo, Francesca Polito, Rosaria Oteri, Mohammed Aguennouz, Giuseppe A. Palumbo, Marco Lolicato, Giovanni Li Volti, Francesco Di Raimondo, Daniele Tibullo, Alessandra Romano
Journal: Blood (2022)
ENT1-AMPD3 As an Imperative Erythrocyte Hypoxia Sensor and Metabolic Regulator Combats Tissue Hypoxia and Fibrosis
Authors: Changhan Chen, Tingting Xie, Yujin Zhang, Weiru Zhang, Benjamin C Brown, Xin Zhang, Rodney Kellems, Angelo D'Alessandro, Yang Xia
Journal: Blood (2022)
Integrating Transcriptomics and Proteomics for the Discovery of Novel Antigen Targets on Surface of Malignant Plasma Cells Amenable for Chimeric Antigen Receptor-T (CAR-T) Cell Approach in the Treatment of Patients with Relapsed/Refractory Multiple Myeloma
Authors: Alexis Talbot, Solène Weill, Eléonore Fox, Léa Meunier, Guillaume Appé, Camille Marijon, Abdelkader Behdenna, Arun P Wiita, Akpéli Nordor, Justin Eyquem
Journal: Blood (2022)
Preliminary Results of a Phase Ⅱ Study of Zanubrutinib Combined with Immunochemotherapy in Patients with CD79A/CD79B-Mutant Diffuse Large B-Cell Lymphoma
Authors: Zhihua Yao, Zheng Yan, Shuna Yao, Haiying Wang, Junfeng Chu, Shuang Zhao, Jie Ma, Bing Wei, Jiawen Zheng, Quande Lin, Zheng Xu, Xinyang Zhao, Yanyan Liu
Journal: Blood (2022)
Bortezomib-Decp Alternating with Daratumumab-Vpd Plus Stem Cell Transplantation, Followed By Maintenance with VP in Ultra-High Risk (UHiR) Newly Diagnosed Multiple Myeloma (NDMM) and Primary Plasma Cell Leukemia (pPCL): A Multicenter, Prospective Phase 2 Pilot Trial (DRAGON CATCHER TRIAL)
Authors: Jin Lu, Yang Liu, Jian Hou, Juan Li
Journal: Blood (2022)